It is indicated for the treatment of [[coronary artery disease]].<ref name="pmid2260140">{{cite journal |vauthors=Fiedler VB, Seuter F, Perzborn E |title=Effects of the novel thromboxane antagonist Bay U 3405 on experimental coronary artery disease |journal=Stroke |volume=21 |issue=12 Suppl |pages=IV149–51 |date=December 1990 |pmid=2260140 |doi= |url=http://pt.wkhealth.com/pt/re/stroke/pdfhandler.00007670-199012001-00037.pdf }}</ref> It has also been used for the treatment of [[asthma]].<ref name="pmid8950952">{{cite journal |vauthors=Endo S, Akiyama K |title=[Thromboxane A2 receptor antagonist in asthma therapy] |language=Japanese |journal=Nippon Rinsho |volume=54 |issue=11 |pages=3045–8 |date=November 1996 |pmid=8950952 |doi= |url=}}</ref>
